Vaxess Technologies, Inc. is a company started by a team of four graduate students from Harvard developing a suite of vaccines on the MIMIX sustained dermal delivery platform that combines high temperature stability, improved efficacy, and simplified delivery to improve global vaccine access.

Property Value
dbo:abstract
  • Vaxess Technologies, Inc. is a company started by a team of four graduate students from Harvard developing a suite of vaccines on the MIMIX sustained dermal delivery platform that combines high temperature stability, improved efficacy, and simplified delivery to improve global vaccine access. (en)
dbo:foundingDate
  • 2011-12-18 (xsd:date)
dbo:numberOfEmployees
  • 16 (xsd:integer)
dbo:wikiPageEditLink
dbo:wikiPageExternalLink
dbo:wikiPageExtracted
  • 2019-09-19 22:59:58Z (xsd:date)
dbo:wikiPageHistoryLink
dbo:wikiPageID
  • 35747818 (xsd:integer)
dbo:wikiPageLength
  • 16125 (xsd:integer)
dbo:wikiPageModified
  • 2019-09-19 22:59:01Z (xsd:date)
dbo:wikiPageOutDegree
  • 34 (xsd:integer)
dbo:wikiPageRevisionID
  • 916647530 (xsd:integer)
dbo:wikiPageRevisionLink
dbp:wikiPageUsesTemplate
dct:subject
rdf:type
rdfs:comment
  • Vaxess Technologies, Inc. is a company started by a team of four graduate students from Harvard developing a suite of vaccines on the MIMIX sustained dermal delivery platform that combines high temperature stability, improved efficacy, and simplified delivery to improve global vaccine access. (en)
rdfs:label
  • Vaxess Technologies (en)
owl:sameAs
foaf:homepage
foaf:isPrimaryTopicOf
foaf:name
  • Vaxess Technologies Incorporated (en)
is dbo:wikiPageRedirects of
is foaf:primaryTopic of